Deep serum discoveries: SDF-1α and HSA fragments in myelodysplastic syndromes

MicroRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cells

(2014) L. S. Arabanian et al.   HAEMATOLOGICA

Redox properties of serum albumin

(2013) Makoto Anraku et al.   BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS

Expression of CXCR4 is an independent prognostic factor for overall survival and progression-free survival in patients with myelodysplastic syndrome

(2012) Yizhuo Zhang et al.   MEDICAL ONCOLOGY

Reduced SMAD7 Leads to Overactivation of TGF-  Signaling in MDS that Can Be Reversed by a Specific Inhibitor of TGF-  Receptor I Kinase

(2010) L. Zhou et al.   CANCER RESEARCH

Identification of disease- and therapy-associated proteome changes in the sera of patients with myelodysplastic syndromes and del(5q)

(2010) C Chen et al.   LEUKEMIA

ProteoMiner™and SELDI-TOF-MS: A robust and highly reproducible combination for biomarker discovery from whole blood serum

(2010) Julia Fröbel et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Elevated tryptase levels selectively cluster in myeloid neoplasms: a novel diagnostic approach and screen marker in clinical haematology

(2009) W. R. Sperr et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Combinatorial hexapeptide ligand libraries (ProteoMiner™): An innovative fractionation tool for differential quantitative clinical proteomics

(2009) Sonja Hartwig et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY